Autoimmune Inner Ear Disease- A Clinical Viewpoint

Document Type : Original


1 Royal Prince Alfred Hospital, The University of Sydney, Sydney, Australia

2 Department of otorhinolaryngology, Amir-Alam Hospital, Tehran University of Medical Sciences, Tehran, Iran


Recent developments in medicine have given us a better insight into a group of disorders known as autoimmune diseases. In particular, advances have occurred in our understanding of the Autoimmune Inner Ear Disease (AIED). In this article, the authors review the different postulated theories in the pathogenesis of this disease. The clinical presentation, the available para-clinical diagnostic tools, and the important differential diagnoses will be summarized. The management methods, including steroid therapy, immunosuppressive medications, other biological agents and intra-tympanic injections, will be addressed. Cochlear implantation as a final solution to the advanced stages of the disease, causing total deafness, will also be discussed.


  1. Khalessi MH. [Autoimmunity and Ear Disease (Otoimmunity)]. Tehran: Tehran University of Medical Sciences; 2003. (Persian)
  2. Agrup C. Immune-mediated audiovestibular disorders in the pediatric population: A review. Int J Audiol 2008; 47(9): 560-5.
  3. Aftab S, Semaan Mt, Murray GS, Megerian CA. Cochlear implantation outcomes in patients with autoimmune and immune-mediated inner ear disease. Otol Neurotol 2010; 31(8): 1337-42.
  4. Alexander TH, Weisman MH, Derebery JM, Espeland MA, Gantz BJ, Gulva AJ, et al. Safety of

high-dose corticosteroids for the  treatment of  autoimmune inner ear disease. Otol Neurotol 2009; 30(4): 443-8.

  1. Bovo R, Ciorba A, Martini A. Vertigo and autoimmunity. Eur Arch Otorhinolaryngol 2010; 267(1): 13-9.
  2. Bovo R, Ciorba A, Martini A. The diagnosis of autoimmune inner ear disease: Evidence and critical pitfalls. Eur Arch Otorhinolaryngol 2009; 266(1): 37-40.
  3. Bunile MC, Geelan -Hansen K, Weber PC, Tuohv VK. Immunosuppressive therapy for autoimmune inner ear disease. Immunotherapy 2009; 1(3): 425-34.
  4. Chau JK, Lin JR, Atashband S, Irvine RA, Westerberg BD. Systematic review of the evidence for the etiology of adult sudden sensorineural hearing loss. Laryngoscope 2010; 120(5): 1011-21.
  5. Dayal VS, Ellman M, Sweiss N. Autoimmune inner ear disease: clinical and laboratory findings and treatment outcome. J Otolaryngol Head Neck Surg 2008; 37(4): 591-6.
  6. Hervier B, Bordure P, Audrain M, Calais C, Masseau A, Hamidou M. Systematic screening for nonspecific autoantibodies in idiopathic sensorineural. Otol Neurotol 2010; 31(4): 687-90.
  7. Karosi T, Szekanecz, Sziklai I. Otosclerosis: An autoimmune disease? Autoimmun Rev 2009; 9(2): 95-101.
  8. Buniel MC, Geelan-Hansen K, Weber PC, Tuohy WK. Immunosuppressive therapy for autoimmune inner ear disease. Immunotherapy 2009; 1(3): 425-34.
  9. Rawal SG, Thakkar KH, Ziai K, Santi PA, Djalilian HR. HLA-B27-associated bilateral Meniere disease. Ear Nose Throat J 2010; 89(3): 122-7.
  10. Schrauwen I, Van Camp G. The etiology of otosclerosis: A combination of genes and environment. Laryngoscopye 2010; 120(6): 1195-202.
  11. Tan CQ, Dong WD, Guo L, Huang H, Wang DY. Auditory function in women with autoimmune inner ear diseases and their offspring. Int J Pediatr Otorhinolaryngol 2009; 73(12): 1702-11.
  12. Yukawa K, Hagiwara A, Ogawa Y, Nishiyama N, Shimizu S, Kawaguchi S, et al. Bilateral progressive hearing loss and vestibular dysfunction with inner ear antibodies. Auris Nasus Larynx; 37(2): 223-8.